Basic information Safety Supplier Related

ZARDAVERINE

Basic information Safety Supplier Related

ZARDAVERINE Basic information

Product Name:
ZARDAVERINE
Synonyms:
  • 6-[4-(DIFLUOROMETHOXY)-3-METHOXYPHENYL]-3(2H)-PYRIDAZINONE
  • ZARDAVERINE
  • ZARDAVENINE
  • 3-[4-(difluoromethoxy)-3-methoxy-phenyl]-1H-pyridazin-6-one
  • 3-[4-(difluoromethoxy)-3-methoxyphenyl]-1H-pyridazin-6-one
  • 3(2H)-Pyridazinone, 6-[4-(difluoromethoxy)-3-methoxyphenyl]-
CAS:
101975-10-4
MF:
C12H10F2N2O3
MW:
268.22
Product Categories:
  • Cyclic Nucleotide related
Mol File:
101975-10-4.mol
More
Less

ZARDAVERINE Chemical Properties

Density 
1.38±0.1 g/cm3(Predicted)
storage temp. 
Store at RT
form 
Off-white to yellow solid.
pka
10.89±0.40(Predicted)
CAS DataBase Reference
101975-10-4
More
Less

Safety Information

WGK Germany 
3

MSDS

More
Less

ZARDAVERINE Usage And Synthesis

Originator

Zardaverine,ZYF Pharm Chemical

Uses

Bronchodilator;Phosphodiesterase III inhibitor

Uses

Zardaverine can selectively inhibit?phosphodiesterase III (PDE III) from human platelets and?phosphodiesterase IV (PDE IV) from human polymorphonuclear leucocytes (PMN).

Definition

ChEBI: A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.

Manufacturing Process

20.8 g of 4-hydroxy-3-methoxyacetophenone are dissolved in 350 ml of dioxane and 350 ml of water by the addition of 30.0 g of sodium hydroxide, and the resulting solution is heated to 60°C. While stirring continuously, chlorodifluoromethane is passed into the solution until uptake of the gas stops (about 4 h). The solution is cooled, and the resulting precipitate is filtered off with suction and washed three times with 40 ml of diethyl ether each time. The solution is diluted with water to twice its volume and likewise extracted three times with 100 ml of diethyl ether each time. The combined ether extracts are dried over magnesium sulfate and evaporated in vacuum; the residue is crystallized from petroleum ether (boiling point 50°-70°C), 19.0 g (70.4% of theory) of 4-difluoromethoxy-3-methoxyacetophenone are obtained, melting point 68°C.
15.0 g of 4-difluoromethoxy-3-methoxyacetophenone are heated with 5.9 g of glyoxylic acid monohydrate at 110°C for 2 h. The melt is then cooled to 60°C, 30 ml of water are added, and dissolution is brought about by addition of 10 ml of concentrated aqueous ammonium solution. 3.2 g of hydrazine hydrate are added, and the mixture is boiled under reflux for 2 h, during which the title compound gradually crystallizes out. After cooling, the precipitate is filtered off with suction, thoroughly washed with water, dried and recrystallized from isopropanol. 10.8 g (58.1% of theory) of the 6-(4- difluoromethoxy-3-methoxyphenyl)-3(2H)pyridazinone are obtained, melting point 204°C.

Therapeutic Function

Bronchodilator, Anti-asthmatic

Biological Activity

Phosphodiesterase inhibitor, selective for PDE3 and 4 (IC 50 values are 0.5 and 0.8 μ M respectively). Also available as part of the Phosphodiesterase Inhibitor Tocriset™ .

ZARDAVERINESupplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801
Email
3bsc@sina.com
BOC Sciences
Email
info@bocsci.com
Haoyuan Chemexpress Co., Ltd.
Tel
86-21-58998985
Email
apisales@chemexpress.com.cn
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-62063333-1
Email
market@aladdin-e.com
MedChemexpress LLC
Tel
609-228-6898
Email
sales@medchemexpress.com